Cited by 73Cell death mechanisms and regulationCancer-related Molecular PathwaysCytokine Signaling Pathways and Interactions

Dependence Receptors and Cancer: Addiction to Trophic Ligands

Gibert, Benjamin, Mehlen, Patrick·2015·Cancer Research

Abstract

Data accumulating over the last 20 years support the notion that some transmembrane receptors are activated not only by their respective ligands but also, differentially, by the withdrawal or absence of these same ligands. In this latter setting, these receptors actively trigger apoptosis. They have been dubbed dependence receptors because their expression confers a state of ligand dependence for survival on the expressing cells. Twenty of these receptors have been identified to date, and several have been shown to inhibit tumor progression by inducing apoptosis. As a corollary, these receptors, or their transduced death signals, are frequently silenced in cancer cells as a selective mechanism to prevent cell death, allowing invasion and metastasis. Drugs aimed at inducing programmed cell death in neoplastic cells by re-engaging the proapoptotic activity induced by unliganded dependence receptors are in late-stage preclinical tests, poised for clinical evaluation. This approach may offer novel opportunities for patient treatments. In this review, we discuss the implications of dependence receptors in limiting cancer progression and address the therapeutic perspectives brought to light by this paradigm. Cancer Res; 75(24); 5171–5. ©2015 AACR.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-3652

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gibert, B., & Mehlen, P.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Mehlen, Patrick
Venue
Cancer Research
Published
2015-12-14
Volume
75
Issue
24
Pages
5171-5175
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2187222358
Cited by
73
References
46
Citations by year
2026: 6 · 2025: 4 · 2024: 3 · 2023: 12 · 2022: 14 · 2021: 3 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 2 · 2016: 3
FWCI
0.42
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Agence Nationale de la Recherche (ANR-10-LABX-0061)
  • Ligue Contre le Cancer
  • Centre National de la Recherche Scientifique
  • Conseil National de la Recherche Scientifique
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
dependence receptors, apoptosis, tumor progression, metastasis, cancer therapy, programmed cell death, receptor signaling, tumor cell survival
MeSH terms
Animals, Humans, Ligands, Neoplasms, Receptors, Cell Surface, Signal Transduction, Apoptosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review